Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1.23B
-
Number of holders
-
567
-
Total 13F shares, excl. options
-
236M
-
Shares change
-
+34.1M
-
Total reported value, excl. options
-
$11.4B
-
Value change
-
+$1.64B
-
Put/Call ratio
-
0.18
-
Number of buys
-
258
-
Number of sells
-
-219
-
Price
-
$48.21
Significant Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q3 2021
643 filings reported holding SNY - Sanofi - Common Stock and American Depositary Receipts as of Q3 2021.
Sanofi - Common Stock and American Depositary Receipts (SNY) has 567 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 236M shares
of 1.23B outstanding shares and own 19.25% of the company stock.
Largest 10 shareholders include Dodge & Cox (94.1M shares), Fisher Asset Management, LLC (17.9M shares), FMR LLC (16.7M shares), BlackRock Inc. (14M shares), BANK OF AMERICA CORP /DE/ (10.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.61M shares), Invesco Ltd. (5.33M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (4.89M shares), Boston Partners (4.59M shares), and LAZARD ASSET MANAGEMENT LLC (3.21M shares).
This table shows the top 567 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.